title: [Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy].
authors: M
authors: M
authors: Heras
authors: A
authors: A
authors: Saiz
authors: M J
authors: MJ
authors: Fernández-Reyes
authors: R
authors: R
authors: Sánchez
authors: P
authors: P
authors: Zurita
authors: C
authors: C
authors: Urrego
mesh_terms: D000208:Acute Disease; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004487:Edema / Q000209:etiology; D004630:Emergencies; D006417:Hematuria / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008181:Lupus Nephritis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000209:etiology* / Q000473:pathology; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011241:Prednisone; D008775:Methylprednisolone